European study with microstent demonstrates lowered IOP, use
Data focuses on patients with combined cataract surgery, device implantation.In cohort 2, the mean IOP stayed the same postoperatively. However, by month 36, the mean number of medications used had dropped to one.

“Of note, we see that the percentage of patients on 0 to 1 medications at baseline was only 31.6% and then increased to 64.1% by 36 months,” Dr. Sarkisian said. “Moreover, at 36 months the number of patients on zero medications was 45%.”

The most commonly seen adverse event was device obstruction (9.4%).


Read more at : http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/news/european-study-microstent-demonstrates-lowered-iop-use-fewer-drugs?page=0,1
Like
Comment
Share